Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

388.14 -1.57 (-0.40%)
Official Closing Price Updated: 7:00 PM EST, Nov 27, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Stryker Corp

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stryker to announce financial results for its first quarter of fiscal year 2023
From Stryker Corporation
Via GlobeNewswire
Stryker Now Offers the Only FDA-Cleared Pyrocarbon Bearing Material Option for Shoulder Hemiarthroplasty
From Stryker
Via Business Wire
The Latest Analyst Ratings for Stryker
Via Benzinga
Stryker announces Annual Meeting of Shareholders
From Stryker Corporation
Via GlobeNewswire
Should Investors Buy This Dividend Growth Stock?
This medical devices company is already up in 2023. Should you buy it? 
Via The Motley Fool
Stryker Expects Good Momentum In 2023 Despite Some Volatility
Via Benzinga
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
Via Benzinga
3 Dividend Champions for Long-Term Income
Dividend Champions have grown their dividend payout for at least 25 years in a row. Here are three to keep in mind for long-term income. 
Via InvestorPlace
Portfolio Highlights: Quarterly Movers & Shakers, March 2023
High quality stocks that generated strong double-digit gains during the past three months. 
Via Talk Markets
Stryker's Earnings: A Preview
Via Benzinga
Texas Rep. Michael C. Burgess Sold Up to $500K Worth of Stryker Stock
Via Benzinga
Stryker's Debt Overview
Shares of Stryker Inc. (NYSE:SYK) increased by 10.06% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its... 
Via Benzinga
Are These Medical Device Makers Getting Ready To Rally?
Current trends and changing demographics are behind growth of medical technology companies. An aging population and a shift to in-home care are among factors. 
Via MarketBeat
BAX: A “Hospital Stock” To Avoid
Baxter International's shares are down nearly 50% over the past three years and have underperformed the broader healthcare industry. 
Via Talk Markets
Interview With David Rolfe of Wedgewood Partners
Motley Fool analyst John Rotonti recently seized the opportunity to interview David Rolfe. 
Via The Motley Fool
Stryker's Q Guidance System Scores FDA Clearance For Cranial Applications
Via Benzinga
Stryker’s Q Guidance System for cranial applications receives FDA clearance
From Stryker
Via Business Wire
8 Analysts Have This to Say About Stryker
Via Benzinga
Expert Ratings for Stryker
Via Benzinga
Stryker declares a $0.75 per share quarterly dividend
From Stryker Corporation
Via GlobeNewswire
General Motors, Bank of America And 2 Other Stocks Insiders Are Selling
The Nasdaq dropped by more than 100 points on Monday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Price Reversals From Recent Highs In Stocks
Stryker Corp is in a bullish phase on both the daily and weekly charts. Since Friday, the stock had a brick pattern confirmed by Monday’s action. 
Via Talk Markets
Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Stryker reports 2022 operating results and 2023 outlook
From Stryker Corporation
Via GlobeNewswire
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named the  SPDR S&P Biotech ETF (NYSE: XBI), saying if you "want growth, 
Via Benzinga
Earnings Scheduled For January 31, 2023
Companies Reporting Before The Bell • Biophytis (NASDAQ:BPTS) is projected to report earnings for its first quarter. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 25, 2023
Via Benzinga
Analyst Boosts Stryker Price On Easing Staffing, Macro Pressures
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023
Via Benzinga
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.